WASHINGTON — A survey found high satisfaction rates among eye care practitioners who prescribed Vyzulta to treat open-angle glaucoma or ocular hypertension.
“There are a multitude of real-world studies looking at patients on [latanoprostene bunod] with [open-angle glaucoma] and ocular hypertension, but there is limited evidence looking at eye care practitioner, or ECP, satisfaction and utilization patterns with the product,” Jason Bacharach, MD, who presented the study at the American Society of Cataract and Refractive Surgery meeting, told Healio.
{{VIDEO}}
The sub-analysis of a retrospective,